CLINICAL_TRIALS
withdrawal
· 2017-05-05
Clinical Trial Update: Does Terlipressin Improve Renal Outcome After Liver Surgery [Phase 2]
Summary
A Phase 2 trial evaluating terlipressin to improve renal outcome after liver surgery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Kidney Failure | Phase 2 | Status: WITHDRAWN